Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores-Reference-Cited by-同舟云学术

Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores

Published:2018-06-05 Issue:11 Volume:7 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Natsuaki Masahiro¹,Morimoto Takeshi²,Yamaji Kyohei³,Watanabe Hirotoshi⁴,Yoshikawa Yusuke⁴,Shiomi Hiroki⁴,Nakagawa Yoshihisa⁵,Furukawa Yutaka⁶,Kadota Kazushige⁷,Ando Kenji³,Akasaka Takashi⁸,Hanaoka Keiichi Igarashi⁹,Kozuma Ken¹⁰,Tanabe Kengo¹¹,Morino Yoshihiro¹²,Muramatsu Toshiya¹³,Kimura Takeshi⁴,

Affiliation:

1. Department of Cardiovascular Medicine, Saga University, Saga, Japan

2. Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan

3. Division of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan

4. Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan

5. Division of Cardiology, Tenri Hospital, Tenri, Japan

6. Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan

7. Division of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan

8. Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan

9. Division of Cardiology, Hanaokaseishu Memorial Cardiovascular Clinic, Sapporo, Japan

10. Division of Cardiology, Teikyo University Hospital, Tokyo, Japan

11. Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan

12. Division of Cardiology, Iwate Medical University Hospital, Morioka, Japan

13. Division of Cardiology, Tokyo Hospital, Tokyo, Japan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

2. Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials

3. Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: A comparison between the DAPT study and 9 other trials evaluating DAPT duration

4. Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention

5. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerebral Small Vessel Disease Burden for Bleeding Risk during Antithrombotic Therapy: Bleeding with Antithrombotic Therapy 2 Study;Annals of Neurology;2024-01-18

2. Comparison of Discriminative Ability of Bleeding Risk Criteria and Scores for Predicting Short- and Mid-Term Major Bleeding Events in Patients Undergoing Percutaneous Coronary Intervention;Circulation Reports;2024-01-10

3. Growth Differentiation Factor-15 and Clinical Outcomes in Lower Extremity Artery Disease;Journal of Atherosclerosis and Thrombosis;2024

4. Bleeding risk factors and real-world antithrombotic therapies in elderly patients with atrial fibrillation undergoing percutaneous coronary intervention: a retrospective study;Journal of Pharmaceutical Health Care and Sciences;2023-12-12

5. Antithrombotic strategy in cancer patients comorbid with acute coronary syndrome and atrial fibrillation;Frontiers in Cardiovascular Medicine;2023-12-12